Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Funding available for basic research on biological/genetic causes of cancer health disparities to support innovative studies and enhance expertise in the field.
Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision) | February 5, 2027 (New) | March 5, 2027 (Renewal/Resubmission/Revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/Resubmission/Revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/Resubmission/Revision)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.
Summary: Supports basic, mechanistic research into biological/genetic causes of cancer health disparities, aiming to advance understanding and resources in this field.
Key Information: Clinical trials are not allowed. Applications requesting ≥$500,000 direct costs in any year require prior contact with NIH program staff.
Description
This opportunity from the National Institutes of Health (NIH), led by the National Cancer Institute (NCI), funds basic research projects (R01 mechanism) focused on understanding the biological and genetic contributors to cancer health disparities. The program aims to support innovative mechanistic studies, development of new methodologies and models, and secondary data analyses that address why certain populations experience higher cancer incidence, more aggressive disease, or poorer outcomes.
The initiative also seeks to build a nationwide cohort of scientists with expertise in cancer health disparities research and to expand resources and tools (e.g., biospecimens, patient-derived models, methods) necessary for this field.
Research must focus on the interplay of race/ethnicity and/or other social determinants with cancer biology to mechanistically explain unequal cancer burdens. Projects must be basic research; immediate clinical translation is not required.
